Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves first combination pill to treat hepatitis C

October 10, 2014Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.

Post navigation

← FDA approves first drug-coated angioplasty balloon catheter to treat vascular disease FDA approves a new ultrasound imaging agent →
Proudly powered by WordPress